FDA Warning Letter — SANTHIGRAM KERALA AYURVEDIC CO. OF US INC
The FDA took a Warning Letter action against SANTHIGRAM KERALA AYURVEDIC CO. OF US INC on May 19, 2022 (Edison, NJ). The action was issued by CDER and concerns drugs products. This facility has 2 recent FDA inspections on record.
Action Details
- Facility
- SANTHIGRAM KERALA AYURVEDIC CO. OF US INC
- Date
- May 19, 2022
- Fiscal Year
- 2022
- Product Type
- Drugs
- Center
- CDER
- Location
- Edison, NJ (United States)